Skip to main content
. 2022 Apr 1;18(5):2040328. doi: 10.1080/21645515.2022.2040328

Figure 4.

Figure 4.

HZ-related prescriptions avoided with RZV vaccination in a population of 1 million adults aged ≥50 years .

aCalculated based on the size of the population vaccinated with RZV and the NNV to avoid one HZ case from RZV cost-effectiveness model.41

bCalculated based on number of HZ cases prevented and painkiller prescription rates.

HZ: herpes zoster; NNV: number needed to vaccinate; RZV: recombinant zoster vaccine